For instance, down-regulation of lncRNA CASC2 promoted tumorigenesis in thyroid carcinoma [24], and overexpression of lncRNA CASC2 inhibited cell proliferation and angiogenesis in gastric cancer [25]. This evidence concerns the gene CASC2 and thyroid gland carcinoma.